iVascular logo — Therapies for living.

iVascular

Therapies for living.

Founded 2010 Germany Germany 289 employees Biotechnology, Health Care +2

General Information

Company Name iVascular
Founded Year 2010
Location Germany Germany +6
Employees 289
Industries Biotechnology, Health Care, Health and Wellness +1
Social

Get notified when iVascular moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iVascular

iVascular, founded in 2010 and headquartered in Germany, is a pioneering force in the Biotechnology and Medical Devices sector. Their mission, encapsulated in the slogan “Therapies for living,” is to create cutting-edge medical devices and therapies that address cardiovascular disorders effectively.

One of the standout features of iVascular is its robust vertical integration strategy. The company excels in transforming basic raw materials such as plastics and metals into advanced cardiovascular devices. This seamless integration from design to production ensures high-quality standards and efficiency.

The company's innovation is driven by a diverse team skilled in biopolymers, coatings, and drug delivery systems. iVascular oversees an expansive technology center featuring over 1000 m² of ISO standard clean rooms, supporting their substantial capabilities in R&D and production.

With a presence in more than 70 countries, iVascular has established an extensive global footprint, offering a comprehensive range of products for interventional cardiology and endovascular procedures.

Taxonomy: Innovative Medical Devices, Cardiovascular System Treatments, Biopolymer Expertise, Drug Delivery Systems, Medical Device Development, Cardiovascular Implants, Vertical Integration, Quality Standards, Clean Room Facilities, Research and Development, Interventional Cardiology, Endovascular Procedures, Drug Eluting Stents, Drug Coated Balloons, Global Sales Network

Services & Products

development of cardiovascular devices
manufacturing of drug-eluting stents
clinical research and trials
innovative medical technologies

Target Customers

hospitals cardiologists vascular surgeons healthcare professionals

No funding data available for iVascular yet.

Get notified when iVascular raises funding

iVascular Alternatives & Competitors

iVascular vs
incuMeD
incuMeD India

IncuMeD “Incubator for Medical Device & Diagnostics”

7 employees
Industrial, Manufacturing
iVascular vs
Idoven
Idoven Spain

Re-defining the way cardiovascular diseases are detected and treated with Artificial Intelligence (A...

Series Unknown
63 employees
AI, Health Care
iVascular vs

Since its founding in 1995, QFI has emerged as one of Europe’s leading and influential consultancy c...

9 employees
Health Care, Medical Devices

FAQ About iVascular

Therapies for living.
iVascular was founded in 2010.
iVascular is headquartered in Germany.
iVascular operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
iVascular has approximately 289 employees.
iVascular offers: development of cardiovascular devices, manufacturing of drug-eluting stents, clinical research and trials, innovative medical technologies.
Top alternatives and competitors to iVascular include incuMeD, Idoven, Quality First International, Advant Medical: a UFP Technologies Company, ALCIS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iVascular and incuMeD are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iVascular and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes